Citations for
1CAKUT4S, ZMYM2
Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations
Connaughton DM, Dai R, Owen DJ, Marquez J, Mann N, Graham-Paquin AL, Nakayama M, Coyaud E, Laurent EMN, St-Germain JR, Blok LS, Vino A, Klämbt V, Deutsch K, Wu CW, Kolvenbach CM, Kause F, Ottlewski I, Schneider R, Kitzler TM, Majmundar AJ, Buerger F, Onuchic-Whitford AC, Youying M, Kolb A, Salmanullah D, Chen E, van der Ven AT, Rao J, Ityel H, Seltzsam S, Rieke JM, Chen J, Vivante A, Hwang DY, Kohl S, Dworschak GC, Hermle T, Alders M, Bartolomaeus T, Bauer SB, Baum MA, Brilstra EH, Challman TD, Zyskind J, Costin CE, Dipple KM, Duijkers FA, Ferguson M, Fitzpatrick DR, Fick R, Glass IA, Hulick PJ, Kline AD, Krey I, Kumar S, Lu W, Marco EJ, Wentzensen IM, Mefford HC, Platzer K, Povolotskaya IS, Savatt JM, Shcherbakova NV, Senguttuvan P, Squire AE, Stein DR, Thiffault I, Voinova VY, Somers MJG, Ferguson MA, Traum AZ, Daouk GH, Daga A, Rodig NM, Terhal PA, van Binsbergen E, Eid LA, Tasic V, Rasouly HM, Lim TY, Ahram DF, Gharavi AG, Reutter HM, Rehm HL, MacArthur DG, Lek M, Laricchia KM, Lifton RP, Xu H, Mane SM, Sanna-Cherchi S, Sharrocks AD, Raught B, Fisher SE, Bouchard M, Khokha MK, Shril S, Hildebrandt F.
Am J Hum Genet. Oct 1;107(4):727-742. doi: 10.1016/j.ajhg.2020.08.013. Epub 2020 Sep 4 2020
2ZMYM2
The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation.
Lezmi E, Weissbein U, Golan-Lev T, Nissim-Rafinia M, Meshorer E, Benvenisty N.
Stem Cell Reports. Jun 9:S2213-6711(20)30186-7. doi: 10.1016/j.stemcr.2020.05.014. Online ahead of print. 2020
3FGFR1, ZMYM2
Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.
Wang Y, Wu X, Deng J, Yu H, Xu R, Zhu Z, Tu S, Hu Y.
Cancer Biol Ther. Aug 2;17(8):785-9. doi: 10.1080/15384047.2016.1210727 2016
4ZMYM2
Screen for multi-SUMO-binding proteins reveals a multi-SIM-binding mechanism for recruitment of the transcriptional regulator ZMYM2 to chromatin.
Aguilar-Martinez E, Chen X, Webber A, Mould AP, Seifert A, Hay RT, Sharrocks AD.
Proc Natl Acad Sci U S A. Sep 1;112(35):E4854-63. doi: 10.1073/pnas.1509716112. Epub 2015 Aug 17. 2015
5ZMYM2, ZMYM3
Characterization of the SUMO-binding activity of the myeloproliferative and mental retardation (MYM)-type zinc fingers in ZNF261 and ZNF198.
Guzzo CM, Ringel A, Cox E, Uzoma I, Zhu H, Blackshaw S, Wolberger C, Matunis MJ.
PLoS One 9(8):e105271. doi: 10.1371/journal.pone.0105271. eCollection 2014. 2014
6FGFR1, SCLLS, ZMYM2
Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
Ren M, Cowell JK.
Blood Jun 23;117(25):6837-47. doi: 10.1182/blood-2010-07-295725. Epub 2011 Apr 28 2011
7FGFR1, SCLLS, ZMYM2
The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.
Goradia A, Bayerl M, Cornfield D.
Int J Clin Exp Pathol 1(5):448-56.PMID: 18787627 2008
8ZMYM2
The oncogenic fusion protein-tyrosine kinase ZNF198/fibroblast growth factor receptor-1 has signaling function comparable with interleukin-6 cytokine receptors.
Baumann H, Kunapuli P, Tracy E, Cowell JK.
J Biol Chem 278(18):16198-208. Epub 2003 Feb 19. 2003
9UBE2A, UBE2B, RAD18, ZMYM2
ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
Kunapuli P, Somerville R, Still IH, Cowell JK.
Oncogene 22(22):3417-23. 2003
10FGFR1, SCLLS, ZMYM2
The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
Kulkarni S, et al.
Genomics 55 : 118-121. 1999
11ZMYM2 , ZMYM6, ZMYM3, ZMYM4
Cloning and mapping of members of the MYM family.
Smedley D, et al.
Genomics 60(2):244-7 1999
12FGFR1, SCLLS, ZMYM2
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA.
Nat Genet 18(1):84-7. 1998
13FGFR1, SCLLS, ZMYM2
The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D, et al.
Hum Mol Genet 7 : 637-642. 1998
14FGFR1, SCLLS, ZMYM2
Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12).
Popovici C, et al.
Proc Natl Acad Sci U S A 95 : 5712-5717. 1998
15FGFR1, SCLLS, ZMYM2
t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
Chaffanet M, et al.
Oncogene 16 : 945-949. 1998
16FGFR1, SCLLS, ZMYM2
Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Goncalves C, Hernandez JM, Jennings BA, Goldman JM, Cross NC.
Blood 92 : 1735-1742. 1998